Biogen Idec, Inc. (Massachusetts) to Rearrange Drug Lineup; CEO Announces Plans to Deemphasize or Sell Off Certain Drugs

Boston Globe -- CAMBRIDGE — Scientists at Biogen Idec Inc.’s warren of research labs in Kendall Square are working to discover treatments for diseases ranging from lupus to multiple sclerosis.

MORE ON THIS TOPIC